Jenscare-B(09877.HK)：Ken-Valve Transcatheter Aortic Valve System Obtains Listing Approval from Hong Kong Department of Health
NewTimeSpace News: Jenscare Scientific Co., Ltd. (09877.HK) announced that its Ken-Valve transcatheter aortic valve system has obtained approval from the Hong Kong Department of Health. The Company is actively advancing the commercialization of this product in Hong Kong.
NewTimeSpace News: On 22 June 2026, Jenscare Scientific Co., Ltd. (09877.HK) issued a voluntary announcement. The Company’s Ken-Valve transcatheter aortic valve system has secured listing approval issued by the Department of Health of the Hong Kong Special Administrative Region, and the Group is pushing forward the commercial launch of the device in Hong Kong.
Backed by its differentiated product advantages, continuous clinical therapy promotion and rich commercialization experience, Ken-Valve has gained wide market recognition. This regulatory approval further validates the clinical potential of the device for treating aortic regurgitation, with or without concomitant aortic stenosis.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
